Ken Fisher's position in Crinetics Pharmaceuticals is currently worth $25.2M. That's 0.01% of their equity portfolio (296th largest holding). The first Crinetics Pharmaceuticals trade was made in Q3 2022. Since then Ken Fisher bought shares six more times and sold shares on four occasions. The investor's estimated purchase price is $25.8M, resulting in a loss of 2.1%.